December 31, 2020
Article
Clinical Viewpoint
Increasing the use and accessibility of mechanical thrombectomy may reduce the burden of stroke on a global scale.
December 30, 2020
Article
NeuroPathways
Patients with MS have an urgent need for therapies that can reverse neurologic disability by promoting remyelination, and RGMa inhibition may help meet that need.
December 29, 2020
Article
Features
Digital biomarkers offer promise to revolutionize the diagnosis and treatment of Alzheimer disease via our increasing ability to gather active and passive data.
December 29, 2020
Article
NeurologyLive Peer Exchange
In a NeurologyLive® Peer Exchange, a panel of migraine specialists discussed the novel therapies in development and those entering the market for the treatment of acute migraine.
December 28, 2020
Article
Letter From the Editor
Guest Editor-in-Chief Karl Doghramji, MD, FAASM, DFAPA, discusses the recent steps forward that have been made in the care of patients with insomnia.
December 26, 2020
Article
Clinical Trial Focus
December 25, 2020
Article
Features
Henry Ford Health System’s investment in advanced DBS technology and its commitment to multidisciplinary care has helped them become a leading treatment center for Parkinson disease and related movement disorders.
December 24, 2020
Article
Cover Story
The pandemic's impact stretches across all aspects of life, and has particularly concerning effects on the sleep of those working on the frontlines providing care of patients.
Evusheld Increased Attenuated SARS-CoV-2 Antibodies From MS B-Cell Depleting Medications
NeurologyLive® Friday 5 — June 24, 2022
Exploiting Anti-CD3 Antibodies, Relevant Biomarkers in Progressive MS: Tanuja Chitnis, MD
FDA Places Clinical Hold on Duchenne Muscular Dystrophy Drug SRP-5051 Amid Safety Concerns